| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $10.0M | -9.9% |
| SG&A Expense | $6.9M | -23.4% |
| Operating Income | -$17.0M | +16.0% |
| Interest Expense | $57 | -99.2% |
| Pre-tax Income | -$23.3M | -17.7% |
| Net Income | -$23.3M | -17.6% |
| EPS (Basic) | -$1.05 | +29.5% |
| EPS (Diluted) | -$1.05 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $0 | — |
| Current Assets | $10.2M | +34.2% |
| Total Assets | $10.2M | +34.2% |
| Current Liabilities | $3.8M | -22.4% |
| Total Liabilities | $6.5M | -8.0% |
| Stockholders' Equity | $3.6M | +661.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.7M | -20.1% |
| Financing Cash Flow | $18.2M | +96.1% |
| +29.5% |